Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07116135 · ClinicalTrials.gov registry record · NA
Speech Understanding and Listening Effort Benefits of Hearing Instruments
A NA study of Hearing Loss, Bilateral, sponsored by Sonova.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07116135: Recruiting NA study of Hearing Loss, Bilateral, sponsored by Sonova.
NCT07116135 is a NA study of Hearing Loss, Bilateral that is actively recruiting participants, run by Sonova. The registered enrollment target is 30 participants, below the 2,335-participant average among 6 other Hearing Loss, Bilateral trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07116135, a NA study of Hearing Loss, Bilateral, is actively recruiting participants, sponsored by Sonova.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical study is to investigate the benefits of hearing instrument use in adults with hearing loss. The main questions it aims to answer are: Does hearing instrument use improve speech understanding and listening effort amount people with hearing loss? Researchers will compare varying models of hearing instruments to see how speech understanding and listening effort are impacted. Participants will be asked to wearing varying hearing instruments and participate in lab-based activities to evaluate their speech understanding, listening effort, and subjective preference.
Primary Outcome
During the CRM task (Bolia et al., 2000), participants are presented with a phrase detailing the following identifiers: target, color, and digit. They must listen for a target name and respond with the corresponding color and digit. Speech intelligibility performance is assessed based on accuracy, or percent correct across all trials conducted in a given condition.
Conditions Studied
Interventions
- DEVICE hearing instruments
Study Locations (1)
Florida
- University of South Florida Auditory Neurosciences & Technology Lab - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-02-05 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT07116135 shows while recruiting
NCT07116135 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 2,335-participant average among 6 other Hearing Loss, Bilateral trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Hearing Loss, Bilateral appearing as the primary indexed condition, and to 1 intervention - of which hearing instruments is the first listed.
NCT07116135 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07116135 about?
NCT07116135 is a clinical study titled "Speech Understanding and Listening Effort Benefits of Hearing Instruments". The goal of this clinical study is to investigate the benefits of hearing instrument use in adults with hearing loss. The main questions it aims to answer are: Does hearing instrument use improve speech understanding and listening effort amount people with hearing loss? Researchers will compare var...
What is the current status of trial NCT07116135?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-02-05. Estimated completion is 2025-12.
What conditions does trial NCT07116135 study?
This clinical trial studies the following conditions: Hearing Loss, Bilateral.
What interventions are being tested in trial NCT07116135?
The interventions under investigation include: hearing instruments (DEVICE).
Who is sponsoring clinical trial NCT07116135?
This trial is sponsored by Sonova, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07116135 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss, Bilateral
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sentence Shaping - DHH
RECRUITING · NA
-
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
RECRUITING · NA
-
Preschool Hearing Screening
RECRUITING · NA
-
Technology-assisted Language Intervention (TALI)
ACTIVE NOT RECRUITING · NA
-
Safety and Effectiveness of Cochlear Implantation in an Expanded Adult Population
ACTIVE NOT RECRUITING · NA
-
Iowa Cochlear Implant Clinical Research Center Hybrid L24 and Standard Cochlear Implants in Profoundly Deaf Infants
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI